Recent advances in whole lung bioengineering have opened new doors for studying lung repair and regeneration ex vivo using acellular human derived lung tissue scaffolds. Methods to decellularise whole human lungs, lobes or resected segments from normal and diseased human lungs have been developed using both perfusion and immersion based techniques. Immersion based techniques allow laboratories without access to intact lobes the ability to generate acellular human lung scaffolds. Acellular human lung scaffolds can be further processed into small segments, thin slices or extracellular matrix extracts, to study cell behaviour such as viability, proliferation, migration and differentiation. Recent studies have offered important proof of concept...
Lung disease is the third leading cause of death worldwide. The shortage of transplantable donor org...
The limited available treatment options for patients with chronic lung diseases, such as fibrosis, l...
Currently, patients with end-stage lung disease are limited to lung transplantation as their only tr...
Recent advances in whole lung bioengineering have opened new doors for studying lung repair and rege...
For patients with end-stage lung diseases, lung transplantation is the only available therapeutic op...
In end-stage lung diseases, the shortage of donor lungs for transplantation and long waiting lists a...
Tissue engineering of autologous lung tissue aims to become a therapeutic alternative to transplanta...
The number of deaths around the globe due to lung diseases is over 9.5 million each year, including ...
Lung diseases are a leading cause of death worldwide. Due to a lack of knowledge of the underlying p...
Acellular whole human lung scaffolds represent a unique opportunity for ex vivo tissue engineering. ...
Lung diseases can be classified as Chronic Obstructive Pulmonary Disorder (COPD), pulmonary fibrosis...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
Chronic lung diseases are one of the leading causes of death worldwide. Lung transplantation is curr...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
AbstractTissue engineering of autologous lung tissue aims to become a therapeutic alternative to tra...
Lung disease is the third leading cause of death worldwide. The shortage of transplantable donor org...
The limited available treatment options for patients with chronic lung diseases, such as fibrosis, l...
Currently, patients with end-stage lung disease are limited to lung transplantation as their only tr...
Recent advances in whole lung bioengineering have opened new doors for studying lung repair and rege...
For patients with end-stage lung diseases, lung transplantation is the only available therapeutic op...
In end-stage lung diseases, the shortage of donor lungs for transplantation and long waiting lists a...
Tissue engineering of autologous lung tissue aims to become a therapeutic alternative to transplanta...
The number of deaths around the globe due to lung diseases is over 9.5 million each year, including ...
Lung diseases are a leading cause of death worldwide. Due to a lack of knowledge of the underlying p...
Acellular whole human lung scaffolds represent a unique opportunity for ex vivo tissue engineering. ...
Lung diseases can be classified as Chronic Obstructive Pulmonary Disorder (COPD), pulmonary fibrosis...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
Chronic lung diseases are one of the leading causes of death worldwide. Lung transplantation is curr...
Chronic respiratory diseases remain a major cause of morbidity and mortality worldwide. The only opt...
AbstractTissue engineering of autologous lung tissue aims to become a therapeutic alternative to tra...
Lung disease is the third leading cause of death worldwide. The shortage of transplantable donor org...
The limited available treatment options for patients with chronic lung diseases, such as fibrosis, l...
Currently, patients with end-stage lung disease are limited to lung transplantation as their only tr...